Guided Therapeutics (GTHP) Shares Outstanding (2010 - 2026)

Guided Therapeutics has disclosed Shares Outstanding (Entity) across 16 years of filings, most recently posting $96.5 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) changed N/A year-over-year to $96.5 million; the TTM figure through Jun 2026 stood at $96.5 million (changed N/A YoY), while the FY2022 annual figure was $32.5 million, up 137.73% from the prior year.
• Shares Outstanding (Entity) came in at $96.5 million for Q2 2026 at Guided Therapeutics, up from $54750.0 in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $96.5 million in Q2 2026 to a low of $49297.0 in Q1 2023.
• Average Shares Outstanding (Entity) over 4 years is $30.6 million, with a median of $27.6 million recorded in 2022.
• Year-over-year, Shares Outstanding (Entity) soared 169319.98% in 2022 and sank 99.78% in 2023.
• Over 4 years, Shares Outstanding (Entity) stood at $32.5 million in 2022, then slumped by 99.85% to $49297.0 in 2023, then rose by 11.06% to $54750.0 in 2024, then surged by 176223.29% to $96.5 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $96.5 million in Q2 2026, $54750.0 in Q1 2024, and $49297.0 in Q1 2023.